Clinical Trials
6 trialsNCT07005102 2026-06-05
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
Phase 2/3 Recruiting
NCT07023289 2026-06-02
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
AbbVie
Phase 2 Recruiting
NCT07324577 2026-05-22
RELAX
Wake Forest University Health Sciences
Phase NA Recruiting
NCT07602504 2026-05-22
China Metastatic Liver Cancer Clinical Registry Cohort Database
Anhui Provincial Hospital
Recruiting
NCT04515810 2026-05-18
Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning
Fred Hutchinson Cancer Center
Phase NA Recruiting
NCT07590505 2026-05-15
ULTIMO
Cancer Research Antwerp
Phase 3 Completed